←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Therapy and ctDNA, Colorectal
Jayesh Desai
MBBS, FRACP
🏢Peter MacCallum Cancer Centre🌐Australia
Associate Director for Clinical Research
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jayesh Desai leads early phase CRC trials at Peter MacCallum Cancer Centre including KRAS G12C inhibitor development and ctDNA-guided adjuvant approaches. He is associate director for clinical research at Peter Mac. His work bridges phase I and perioperative CRC strategy.
Share:
🧪Research Fields 研究领域
early phase trials
KRAS G12C
CRC drug development
MRD ctDNA adjuvant
Peter Mac
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jayesh Desai 的研究动态
Follow Jayesh Desai's research updates
留下邮箱，当我们发布与 Jayesh Desai（Peter MacCallum Cancer Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment